GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Price-to-Tangible-Book

NextCell Pharma AB (OSTO:NXTCL) Price-to-Tangible-Book : 0.90 (As of May. 26, 2024)


View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Price-to-Tangible-Book?

As of today (2024-05-26), NextCell Pharma AB's share price is kr1.455. NextCell Pharma AB's Tangible Book per Share of Feb. 2024 for the quarter that ended in Feb. 2024 was kr1.62. Hence, NextCell Pharma AB's Price to Tangible Book Ratio of today is 0.90.

The historical rank and industry rank for NextCell Pharma AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:NXTCL' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.9   Med: 3.48   Max: 26.5
Current: 0.9

During the past 9 years, NextCell Pharma AB's highest Price to Tangible Book Ratio was 26.50. The lowest was 0.90. And the median was 3.48.

OSTO:NXTCL's Price-to-Tangible-Book is ranked better than
86.32% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs OSTO:NXTCL: 0.90

A closely related ratio is called PB Ratio. As of today, NextCell Pharma AB's share price is kr1.455. NextCell Pharma AB's Book Value per Sharefor the quarter that ended in Feb. 2024 was kr1.62. Hence, NextCell Pharma AB's P/B Ratio of today is 0.90.


NextCell Pharma AB Price-to-Tangible-Book Historical Data

The historical data trend for NextCell Pharma AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Price-to-Tangible-Book Chart

NextCell Pharma AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only 4.59 9.41 3.32 1.89 1.63

NextCell Pharma AB Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.49 1.95 1.63 1.63 1.64

Competitive Comparison of NextCell Pharma AB's Price-to-Tangible-Book

For the Biotechnology subindustry, NextCell Pharma AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextCell Pharma AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's Price-to-Tangible-Book falls into.



NextCell Pharma AB Price-to-Tangible-Book Calculation

NextCell Pharma AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Feb. 2024 )
=1.455/1.624
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


NextCell Pharma AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


NextCell Pharma AB (OSTO:NXTCL) Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines